Siemens Medical Shanghai Laboratory Diagnostics New Factory held groundbreaking ceremony
The foundation of the new Shanghai plant marks the expansion of Siemens Medical 's existing manufacturing capabilities in Shanghai, China. The Shanghai Park will be the first production base of Siemens Medical in China with both diagnostic imaging and laboratory diagnostic products.
The products and solutions provided by the new factory will further promote the promotion of precision medicine and conversion diagnosis and treatment, and fully support the “Healthy China 2030†plan.
The total investment of the new plant is RMB 3 billion. It is expected to create about 500 new jobs after full-load production, further emphasizing Siemens Medical's commitment to the Chinese market.
Siemens Medical announced that it has invested RMB 3 billion to build a new laboratory diagnostic plant and held a groundbreaking ceremony in Shanghai today. After the completion of the plant, Shanghai will become a comprehensive innovation base for Siemens medical imaging diagnostics and laboratory diagnostic products.
It is reported that the new factory is expected to create about 500 new jobs after full production. Shang Yuying, Director of the Shanghai Municipal Commission of Commerce, Pan Baishen, Chairman of the China Medical Education Association's Laboratory Medicine Committee, Michael Reitermann, Member of the Siemens Medical Management Committee, President of the Diagnostics Business, Tao Lin, President of Siemens Healthcare Asia Pacific, Vice President, Diagnostic System, Siemens Medical Greater China The responsible person Guo Yuming and other guests attended the groundbreaking ceremony. After the ceremony, Wu Qing, deputy mayor of Shanghai, met with Siemens Medical Michael Reitermann and Tao Lin at the City Hall Building.
Wu Qing, deputy mayor of Shanghai, met with Siemens Medical Michael Reitermann and Tao Lin
Michael Reitermann, member of the Siemens Medical Management Committee and president of the Diagnostics Business, said: "The foundation of the new laboratory for the diagnosis of the Shanghai laboratory is not only an important investment in the future development of the Siemens medical diagnostics business, but also to expand our business in China. Demonstrate our long-term commitment to China's and the growing healthcare market across Asia Pacific."
Professor Pan Baishen, chairman of the Chinese Medical Education Association's Laboratory Medicine Committee and Professor of the Zhongshan Hospital of Fudan University, congratulated the Siemens Medical Laboratory Diagnostic Factory. He said in his speech: "Siemens Medical and China's in vitro diagnostic customers and industry associations have good relations. cooperation. I believe the completion of the new plant Siemens medical laboratory diagnosis will lead to better services for the medical industry, the health care professional can more easily use high-quality medical products. "
The new laboratory diagnostics facility will further expand Siemens Global Manufacturing's manufacturing footprint and will better meet the evolving needs of Chinese healthcare providers by collecting market insights and providing more localized products and solutions.
“The new laboratory diagnostics facility will be Siemens Medical's first in vitro diagnostic reagents facility in the Asia Pacific region, producing clinical chemistry and immunoassay reagents. In addition, the Shanghai campus will be the first in vitro and in vivo diagnostics for Siemens Healthcare in the region. The production base of the product," said Tao Lin, president of Siemens Healthcare Asia Pacific.
Wang Wei, President of Siemens Medical Greater China, said: "Our new factory in Shanghai will bring many improvements to medical service providers and patients. Siemens Medical China will further enhance its strength and actively respond to the 'Healthy China 2030' plan for China. Medical reform contributes."
endotracheal tube,ett tube,tracheal tube,intubation tube
2 MEDS TECHONOLOGY CO.,LTD , https://www.2-meds.com